{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T18:34:07Z","timestamp":1762022047439,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtcvs.2020.03.065","type":"journal-article","created":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T09:45:31Z","timestamp":1586079931000},"page":"1042-1043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Commentary: Yin and Yang: Antiplatelet and lipid-lowering therapies to prevent vein graft thrombosis and atherosclerosis after coronary artery bypass graft surgery"],"prefix":"10.1016","volume":"163","author":[{"given":"Alexander","family":"Kulik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2020.03.065_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/HCO.0000000000000331","article-title":"Secondary prevention after coronary artery bypass graft surgery: a primer","volume":"31","author":"Kulik","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0003-4975(96)00528-0","article-title":"Endothelial cell injury in cardiovascular surgery","volume":"62","author":"Verrier","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific\u00a0statement from the American Heart Association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.CIR.102.2.157","article-title":"Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG investigators","volume":"102","author":"Knatterud","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jtcvs.2020.03.039","article-title":"Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting","volume":"163","author":"Zhu","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib10","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial","volume":"319","author":"Zhao","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/heartjnl-2012-302449","article-title":"Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study","volume":"98","author":"Mannacio","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"10.1016\/j.jtcvs.2020.03.065_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtcvs.2018.05.123","article-title":"Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: the aggressive cholesterol therapy to inhibit vein graft events randomized clinical trial","volume":"157","author":"Kulik","year":"2019","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320307558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320307558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:17:11Z","timestamp":1758388631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522320307558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022522320307558"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.065","relation":{},"ISSN":["0022-5223"],"issn-type":[{"type":"print","value":"0022-5223"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commentary: Yin and Yang: Antiplatelet and lipid-lowering therapies to prevent vein graft thrombosis and atherosclerosis after coronary artery bypass graft surgery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}